Researchers have announced a major medical breakthrough after a recent clinical trial showed that several patients in the United States have effectively been freed from insulin dependence.
A team at the University of Chicago Medicine Transplant Institute revealed results from an ongoing study involving individuals diagnosed with Type 1 Diabetes - a chronic autoimmune condition in which the body’s immune system destroys insulin-producing cells in the pancreas.
Unlike Type 2 Diabetes, patients with Type 1 diabetes cannot naturally regulate blood sugar levels due to the absence of insulin. Without treatment, blood glucose can rise to dangerous levels, forcing the body to break down fat for energy. This process produces acids known as ketones, which can lead to a life-threatening condition called Diabetic Ketoacidosis - associated with brain swelling, kidney failure, heart complications, and even death.
In the trial, 10 patients with Type 1 diabetes underwent transplantation of islet cells - specialized clusters of cells in the pancreas responsible for producing hormones that regulate blood sugar.
Remarkably, within just four weeks of the procedure, all 10 patients became insulin-independent. Their bodies regained the ability to produce insulin naturally, eliminating the need for costly daily injections.
Researchers describe the results as highly promising, offering hope that such treatments could transform the future of diabetes care if proven effective on a larger scale.
